Molecular Oncology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish contributions novel findings in research to molecular aspects of all types of human cancers. This section ranges from basic sciences to preclinical research. We encourage submission of high-quality manuscripts that provide novel mechanistic insights and details of the molecular signatures of oncogenic transformation. We also encourage submission of high-quality manuscripts that focus on translating basic molecular knowledge to new clinical applications in oncology. The scope of this section includes, but is not limited to, the following:
- Biological processes, like gene activity in relation with specific molecular pathways, in the development and progression of cancers
- Mechanisms of metastasis (vascular and lymphatic dissemination and seeding)
- Molecular interactions in the tumor microenvironment, including tumor-immune interactions
- Genomic profiling of human cancers and any other ‘systems biology’ approaches in understanding development of human cancers
- Preclinical research that leads to novel therapies derived from molecular processes and cellular interactions, including gene therapy, therapy based on biologicals, hormonal therapy, and cancer vaccines and other types of immunotherapies
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- The Transcriptome Complexity in Cancer and Leukemia: Alternative Splicing and Beyond (Deadline: 15 October 2023)
- Advances in Pathogenesis and Treatment of Skin Cancer (Deadline: 15 October 2023)
- Pathogenesis and Treatments of Head and Neck Cancer (Deadline: 20 October 2023)
- New Therapeutic Strategies for Lung Cancer: An Update (Deadline: 20 October 2023)
- New Advances in B-cell Lymphoma Biology (Deadline: 27 October 2023)
- Alterations to Signalling Pathways in Cancer Cells 2023 (Deadline: 28 October 2023)
- Microbiota and Cancer 3.0 (Deadline: 30 October 2023)
- Circulating Cell-Free Nucleic Acids and Cancers 2.0 (Deadline: 30 October 2023)
- State-of-the-Art Molecular Oncology in Brazil 2.0 (Deadline: 30 October 2023)
- Emerging Therapeutic Targets for Solid Tumors (Deadline: 31 October 2023)
- Metals and Cancer (Deadline: 31 October 2023)
- Molecular Insight into Leukemia (Deadline: 31 October 2023)
- Exploring Novel Molecular, Metabolic and Cellular Mechanisms for Developing New Therapeutic Targets against Childhood Cancers (Deadline: 31 October 2023)
- Ovarian Cancer: Advances on Pathophysiology and Therapies (Deadline: 31 October 2023)
- Molecular Advances in Cancer Therapy 2.0 (Deadline: 31 October 2023)
- Glioblastoma: State of the Art and Future Trends (Deadline: 31 October 2023)
- Update on Immunotherapies for Cancer (Deadline: 31 October 2023)
- Research Progress of Tumor Endothelial Cells (Deadline: 31 October 2023)
- Mesenchymal Stem Cells and Cancer (Deadline: 31 October 2023)
- Molecular Advances in Cancer Radiotherapy (Deadline: 31 October 2023)
- New Molecular Mechanisms and Advanced Therapies for Solid Tumors (Deadline: 31 October 2023)
- Molecular Biomarkers in Cancers: Advances and Challenges (Deadline: 31 October 2023)
- Cancer Biophysics: Recent Advances in the Mechanobiology and Mechanomedicine of Cancer (Deadline: 31 October 2023)
- Aldehyde Dehydrogenase in Cancer (Deadline: 31 October 2023)
- Molecular Mechanisms and Therapies of Lung Cancer (Deadline: 31 October 2023)
- Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 October 2023)
- New Players in Pancreatic Cancer: Microbiome and Metabolic Syndrome Signalling (Deadline: 31 October 2023)
- Recent Molecular Research for Glioblastoma (Deadline: 31 October 2023)
- Molecular Mechanisms and Therapies of Brain Cancers (Deadline: 31 October 2023)
- Advances in Molecular Studies of Hereditary Cancers (Deadline: 31 October 2023)
- Molecular Researches in Cancer Radiotherapy (Deadline: 31 October 2023)
- Combating Drug Resistance in Cancer: From Novel Biomarkers to Enhanced Therapeutic Efficacy—2nd Edition (Deadline: 31 October 2023)
- Current Research on Cancer Drug Resistance (Deadline: 31 October 2023)
- The Mast Cell in Breast Cancer: Friend or Foe (Deadline: 31 October 2023)
- Latest Review Papers in Molecular Oncology 2023 (Deadline: 31 October 2023)
- Antibody Therapy for Hematologic Malignancies (Deadline: 31 October 2023)
- Molecular Diagnostic Strategies for Prediction and Prognosis of Gastric Cancer (Deadline: 31 October 2023)
- Genetics and Epigenetics of Cancer Cells and Tumor Microenvironment (Deadline: 31 October 2023)
- Adhesion-Mediated Signaling during Cancer Progression (Deadline: 31 October 2023)
- Endometrial Cancer: From Molecular Pathology to Novel Therapeutic Approaches (Deadline: 31 October 2023)
- Molecular Research and Treatment of Prostate Cancer (Deadline: 31 October 2023)
- The Role of Cancer Stem Cells in Anticancer Therapy Resistance (Deadline: 31 October 2023)
- Innovative Approaches for Targeted Cancer Therapies (Deadline: 31 October 2023)
- Liquid Biopsy in the Approach of Non-communicable Chronic Diseases (NCCD) and Cancer (Deadline: 31 October 2023)
- Systemic and Mucosal Inflammation in Colorectal Cancer: Underlying Factors, Significance, and Related Biomarkers (Deadline: 31 October 2023)
- Molecular Mechanisms and Immunotherapy of Soft Tissue and Bone Sarcomas (Deadline: 31 October 2023)
- DNA Damage, Oxidative Stress and Metabolism in Cancer (Deadline: 31 October 2023)
- Cancer Suicide Gene Therapy (Deadline: 10 November 2023)
- Role of MicroRNAs in Cancer Development and Treatment 2.0 (Deadline: 15 November 2023)
- New Chemotherapeutics, Alternative Methods & Old Challenges (Deadline: 15 November 2023)
- Reprogramming the Tumor Microenvironment in Pancreatic Cancer (Deadline: 20 November 2023)
- Circulating Tumor Cells, Liquid Biopsies, and Precision Oncology (Deadline: 20 November 2023)
- Ozone Therapy in Cancer Treatment (Deadline: 29 November 2023)
- Oral Squamous Cell Carcinoma—Pathogenetic, Diagnostic and Therapeutic Perspectives (Deadline: 29 November 2023)
- Aberrations of DNA Repair Pathways in Prostate Cancer 2.0 (Deadline: 29 November 2023)
- Recent Advances in Tumor Microenvironment and Molecular Targeting in Multiple Myeloma and Chronic Lymphocytic Leukemia (Deadline: 29 November 2023)
- Tumor Microenvironment 2023 (Deadline: 29 November 2023)
- Recent Advances in Endometrial Cancer (Deadline: 29 November 2023)
- DNA Damage Repair in Cancer: Genetics, Molecular Mechanisms, Diagnostic and Therapeutic Perspectives (Deadline: 30 November 2023)
- Bladder Cancer: Molecular Advances in Pathology, Diagnostics and Therapeutics 2.0 (Deadline: 30 November 2023)
- Current Research on Cancer Biology and Therapeutics (Deadline: 30 November 2023)
- Role of p53 Family in Targeted Therapy of Cancers (Deadline: 30 November 2023)
- Molecular Research on Neuroblastoma: Current Status and Future Perspectives (Deadline: 30 November 2023)
- Advances in the Development of Anticancer Drugs (Deadline: 30 November 2023)
- Research into Using Natural-Product-Related Medicines for Cancer (Deadline: 30 November 2023)
- Insights into Hepatocellular Carcinoma: From Pathophysiology to Novel Therapies (Deadline: 30 November 2023)
- The Emerging Role of Neutrophils in Cancer: Molecular Aspects of Plasticity and Potential Therapeutic Targets (Deadline: 30 November 2023)
- Trends and Prospects in Electroporation-Based Treatment for Tumors (Deadline: 30 November 2023)
- Non-small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 30 November 2023)
- Recent Advances in Cancer Biomarkers, Artificial Intelligence and Emerging Technologies (Deadline: 30 November 2023)
- Optical Molecular Imaging in Cancer Research and Diagnosis (Deadline: 30 November 2023)
- Molecular Mechanisms of Breast Cancer: Toward Advanced Therapy (Deadline: 30 November 2023)
- Molecular and Cellular Mechanisms of Pancreatic Cancer (Deadline: 30 November 2023)
- Pathophysiology to Novel Therapeutic Approaches for Leukemia (Deadline: 30 November 2023)
- Molecular-Based Treatment in Breast and Gynecologic Cancer (Deadline: 30 November 2023)
- Molecular Insights into Epigenetics in Cancer (Deadline: 30 November 2023)
- Contribution of Cancer-Targeting Drugs toward Faster Clinical Application 3.0 (Deadline: 30 November 2023)
- TRP Channels in Cancer: New Avenues for Diagnosis, Prognostication, and Therapy (Deadline: 30 November 2023)
- Molecular Mechanism of Anti-cancer Drugs (Deadline: 30 November 2023)
- NK Cells, Immune Response in Pathology and Cancer 2.0 (Deadline: 30 November 2023)
- Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment 2.0 (Deadline: 30 November 2023)
- Advances in Gynecological Cancers 2.0 (Deadline: 30 November 2023)
- Nutrition and Cancer: Molecular Mechanisms between Nutrition and Cancer Etiology, Prevention, and Treatment (Deadline: 30 November 2023)
- Targeted Therapies and Molecular Methods in Cancer 2.0 (Deadline: 30 November 2023)
- Insulinoma: From Molecular Mechanisms to Therapies (Deadline: 30 November 2023)
- Decoding Cancer's Immune Escape: Insights into MHC Class I Antigen Presentation Dysfunction (Deadline: 30 November 2023)
- Novel Molecular Pathways in Oncology 2.0 (Deadline: 30 November 2023)
- The Role of Estrogen and Its Receptors in the Development and Therapy of Cancer (Deadline: 30 November 2023)
- Advanced Molecular Research in Tumors (Deadline: 30 November 2023)
- New Anticancer Agents: Design, Synthesis and Evaluation (Deadline: 30 November 2023)
- Anti-cancer Drug Chemoresistance and New Chemosensitization Strategies (Deadline: 10 December 2023)
- Cancer Genomics (Deadline: 10 December 2023)
- Cancer-Related Biochemical Pathways: From Tumor Outgrowth, Metastasis to Novel Targeted Therapy (Deadline: 15 December 2023)
- Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment (Deadline: 15 December 2023)
- Pathways Regulating Macrophage Phagocytosis of Tumor Cells (Deadline: 15 December 2023)
- Molecular Research on Breast Cancer Diagnosis and Treatment (Deadline: 15 December 2023)
- Biomechanics and Molecular Research on Glioblastoma (Deadline: 15 December 2023)
- From Omics to Therapeutic Targets in Cancer 2.0 (Deadline: 20 December 2023)
- New Insights into Endometrial Cancer 2023 (Deadline: 25 December 2023)
- Non-Small-Cell Lung Cancer (NSCLC): The Changes of Molecular Immunotherapy and Targeted Therapy 2.0 (Deadline: 25 December 2023)
- Endometrial Carcinoma: Current Insights and Future Perspectives (Deadline: 30 December 2023)
- Molecular Researches in Soft Tissue Sarcomas (Deadline: 30 December 2023)
- Paracrine and Metabolic Adaptation in Cancer Progression (Deadline: 30 December 2023)
- Advance in Targeted Cancer Therapy and Mechanisms of Resistance—2nd Edition (Deadline: 30 December 2023)
- Advances in Melanoma and Skin Cancers (Deadline: 30 December 2023)
- Cellular Intrinsic Modulators in the Pathogenesis of Cancer and Inflammatory Diseases (Deadline: 30 December 2023)
- Emerging Therapies for Glioblastoma (Deadline: 30 December 2023)
- Molecular Mechanisms of Angiogenesis and Cancer (Deadline: 30 December 2023)
- Cancer Biomarker: Current Status and Future Perspectives (Deadline: 30 December 2023)
- Molecular Mechanisms of Liver Cancer (Deadline: 30 December 2023)
- Lung Cancer: From Molecular Mechanisms to Novel Therapeutics (Deadline: 30 December 2023)
- Targeting PI3K/mTOR Signaling in Cancers (Deadline: 30 December 2023)
- Energy Metabolisms in Cancer (Deadline: 30 December 2023)
- Molecular Mechanisms and Targeted Therapies for Glioblastoma (Deadline: 30 December 2023)
- State-of-the-Art Molecular Oncology in Chile (Deadline: 30 December 2023)
- Recent Advances in Chemoprevention (Deadline: 30 December 2023)
- Molecular Biology of Gynecological Cancers: From Bench to Bedside (Deadline: 31 December 2023)
- Cancer Biomarkers and Bioinformatics (Deadline: 31 December 2023)
- Head and Neck Tumors: New Diagnostic, Prognostic and Therapeutic Opportunities (Deadline: 31 December 2023)
- Molecular Biology of the Thyroid Cancer and Thyroid Dysfunctions (Deadline: 31 December 2023)
- Hormone Signaling in Cancers and Cancer-Promoting Pathologies (Deadline: 31 December 2023)
- miRNAs in Carcinogenesis of Solid and Hematological Malignancies (Deadline: 31 December 2023)
- The Occurrence, Evolution and Treatment of Glioblastoma (Deadline: 31 December 2023)
- Role of Mitochondria in Cancer (Deadline: 31 December 2023)
- Anticancer Therapy (Deadline: 31 December 2023)
- Cancer Genomics and Precision Oncology (Deadline: 31 December 2023)
- MicroRNAs in Cancer Therapy 2.0 (Deadline: 31 December 2023)
- Recent Insights into Colorectal Cancer Treatment (Deadline: 31 December 2023)
- Immunotherapy in Tumors: Treatments, Complications and Diagnostic Evaluation of Response (Deadline: 31 December 2023)
- Tumor Microenvironments: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression (Deadline: 31 December 2023)
- New Perspectives in Prostate Cancer: From Pathophysiology to Novel Therapies (Deadline: 31 December 2023)
- Immunotherapies in Hepatocellular Carcinomas (Deadline: 31 December 2023)
- Molecular Biomarkers in Cancer and Their Applications 2.0 (Deadline: 31 December 2023)
- Chronic Liver Disease and Hepatocellular Carcinoma (Deadline: 31 December 2023)
- Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers 2.0 (Deadline: 31 December 2023)
- The Role of Macrophages in Cancers (Deadline: 31 December 2023)
- Molecular Targets in Preventing Pancreatic Cancer Progression (Deadline: 31 December 2023)
- Recent Advances in Gastrointestinal Cancer (Deadline: 31 December 2023)
- Molecular Mechanisms and Therapies of Pancreatic Cancer (Deadline: 31 December 2023)
- From Basic Science to Treatment Strategies: Personalized Cancer Therapy (Deadline: 31 December 2023)
- New Research on Oral Fibrosis and Oral Cancer (Deadline: 31 December 2023)
- Integrative Oncology: From the Lab to New Therapeutic Possibilities - 2nd Edition (Deadline: 31 December 2023)
- Molecular Mechanisms and Therapies of Oral Cancer (Deadline: 31 December 2023)
- Tumor Microenvironment in Cancer Cell Metastasis (Deadline: 31 December 2023)
- Advances in Novel Cancer Medicine (Deadline: 31 December 2023)
- Emerging Role of Immunogenic Cell Death in Cancer Therapy (Deadline: 31 December 2023)
- Breast Cancers: From Molecular Basis to Therapy (Deadline: 31 December 2023)
- Novel Molecular Mechanisms of Kidney Injury Associated with Oncology: Onconephrology (Deadline: 31 December 2023)
- Molecular Research and Novel Therapy of Pancreatic Cancer (Deadline: 31 December 2023)
- Cancer Prevention with Molecular Target Therapies 2023 (Deadline: 31 December 2023)
- Biomarkers of Tumor Progression, Prognosis and Therapy (Deadline: 31 December 2023)
- Pathogenesis and Therapy of Oral Carcinogenesis 2.0 (Deadline: 14 January 2024)
- Anti-cancer Drugs from Natural Resources (Deadline: 15 January 2024)
- Recent Advances in Immunotherapy of Multiple Myeloma (Deadline: 15 January 2024)
- Tumour Repopulation Revisited – Molecular Mechanisms and Current Challenges in Radiobiology and Radiotherapy (Deadline: 15 January 2024)
- Genomic Oncology and Medicine in Leukemia: From Molecular Pathogenesis to Novel Therapeutic Approaches (Deadline: 15 January 2024)
- Fifty Years of Targeted Therapy in Cancer: Past, Present and Future (Deadline: 20 January 2024)
- Breast Cancer, Metastatic Breast Cancer, Therapeutic Approaches 2.0 (Deadline: 20 January 2024)
- Recent Advances in Molecular Mechanisms of Human Papillomavirus Family (HPV) Induced Oncogenesis (Deadline: 20 January 2024)
- Navigating Precision Oncology: Integrating Biomarkers into Clinical Practice (Deadline: 25 January 2024)
- Advance in Cancer Biomarker: From Molecular Mechanisms to Potential Therapy (Deadline: 30 January 2024)
- Molecular Basis of Odontogenic Tumors and Odontogenic Cysts (Deadline: 30 January 2024)
- Multidisciplinary Treatment of Urologic Cancer (Deadline: 30 January 2024)
- Breast Cancer Mechanistic Insights and Targeted Therapies 2.0 (Deadline: 30 January 2024)
- Liver Cancer 3.0 (Deadline: 30 January 2024)
- Molecular Research and New Therapy in Melanoma and Other Skin Cancers (Deadline: 30 January 2024)
- Molecular Therapies and Mechanisms of Gynecological Cancers (Deadline: 30 January 2024)
- Molecular Research on the Pancreatic Cancer (Deadline: 30 January 2024)
- Novel Therapeutic Targets in Cancers 2.0 (Deadline: 30 January 2024)
- State-of-the-Art Molecular Oncology in Mexico, 2nd Edition (Deadline: 30 January 2024)
- Sexual Dimorphism in Cancers: Gender-Related Mechanisms in Cancer Development (Deadline: 30 January 2024)
- Renal Cell Carcinoma: Novel Insights into Pathophysiology, Diagnosis and Therapy (Deadline: 30 January 2024)
- Mechanisms Underlying Cancer Chemoresistance: A Starting Point to Identify New Anticancer Strategies (Deadline: 31 January 2024)
- Gynecologic Cancer: From Molecular, Cellular Mechanisms to Novel Therapies (Deadline: 31 January 2024)
- Myeloid-Derived Suppressor Cells in Cancer (Deadline: 31 January 2024)
- Gastrointestinal Disorder and Cancer: Biochemical and Molecular Insight (Deadline: 31 January 2024)
- Unraveling the Role of the Relaxin-Like Peptide Family in Cancer: Mechanisms, Impacts and Therapeutic Potential (Deadline: 31 January 2024)
- Leptomeningeal Metastasis in the Paediatric Population (Deadline: 31 January 2024)
- The Role of Peptides and Peptide Syntheses in Cancer Therapy (Deadline: 31 January 2024)
- Proteomics of Human Peripheral Blood Mononuclear Cells in Cancer (Deadline: 31 January 2024)
- New Biomarkers and Therapeutics in Hematological Neoplasias (Deadline: 31 January 2024)
- Recent Advances in Lung Cancer (Deadline: 31 January 2024)
- Acute Leukemia: From Basic Research to Clinical Application (Deadline: 31 January 2024)
- Intercellular Communication in the Tumor Microenvironment (Deadline: 31 January 2024)
- Epigenetics and Immunotherapy in Cancer (Deadline: 31 January 2024)
- Molecular Mechanism of Gastric Cancer (Deadline: 31 January 2024)
- Hormone-Sensitve Cancers: Pathogenesis and Therapeutics (Deadline: 31 January 2024)
- Advanced Research on Biomarkers in Gastrointestinal Cancer (Deadline: 31 January 2024)
- Advances and Mechanisms in Breast Cancer (Deadline: 31 January 2024)
- Current and Future Roles of Tumor Markers in Prostate Adenocarcinoma (Deadline: 31 January 2024)
- Advances in Pathogenesis and Treatment of Multiple Myeloma (Deadline: 31 January 2024)
- Targeted Therapy and Molecular Strategies for Gynecological Cancer (Deadline: 10 February 2024)
- Cancer Immunotherapy: Tumor Microenvironment, Biomarker Discovery and Immune Resistance 2.0 (Deadline: 10 February 2024)
- Photodynamic Therapy and Targeted PDT for Cancer Treatment (Deadline: 15 February 2024)
- Transcriptional Regulation and Targeted Therapy in Cancer (Deadline: 15 February 2024)
- Recent Advances in Thyroid Cancer 2.0 (Deadline: 20 February 2024)
- Molecular Basis and Advances of Targeted Therapy for Breast Cancer (Deadline: 20 February 2024)
- Human Papillomavirus and Cancers: Advances and Future Prospects (Deadline: 20 February 2024)
- Cancer Stem Cell and Differentiation 2023 (Deadline: 20 February 2024)
- Exploring Markers and Molecular Pathogenesis of Cancer: Genitourinary and Gynecological Tumors (Deadline: 25 February 2024)
- New Advances to Overcome Resistance in Tumor Therapy (Deadline: 26 February 2024)
- Molecular Research on Bladder Cancer 2.0 (Deadline: 26 February 2024)
- Current Research for Ovarian Cancer Biology and Therapeutics (Deadline: 26 February 2024)
- Colorectal Cancer: A Molecular Genetics Perspective (Deadline: 28 February 2024)
- Discoveries of Genetic Regulations in Onco-Progression (Deadline: 28 February 2024)
- Recent Advances in Breast Cancer Research 2.0 (Deadline: 28 February 2024)
- Lung Cancer: From Molecular Basis to Genome-Guided Therapy and Immunotherapy 2.0 (Deadline: 28 February 2024)
- The Carcinogenetic Potential of Human Papilloma Virus: From Experimental Studies to Targeted Therapy (Deadline: 28 February 2024)
- Interplay between B Cells and Gut Microbiome in Cancer (Deadline: 29 February 2024)
- Molecular and Cellular Mechanisms of Cancers: Bone and Soft Tissue Sarcomas (Deadline: 29 February 2024)
- Signaling Pathways Dysregulation in Cancer: Advances and New Therapeutics Hopes (Deadline: 29 February 2024)
- Advances and Perspectives in Molecular Tumor Therapy (Deadline: 29 February 2024)
- Melatonin and Vitamins: New Insights into Cancer Therapies (Deadline: 29 February 2024)
- Emerging Treatment of Glioblastoma Multiforme (Deadline: 29 February 2024)
- The Hallmarks of Cancer Stem Cells (Deadline: 29 February 2024)
- Molecular and Therapeutic Advances in Glioblastomas (Deadline: 29 February 2024)
- Advances in the Diagnosis and Treatment of Non-small Cell Lung Cancer (Deadline: 29 February 2024)
- Predictive, Prognostic Biomarkers and Therapeutic Targets of Breast Cancer (Deadline: 29 February 2024)
- Molecular Mechanism of Cancer Research and Therapies (Deadline: 29 February 2024)
- New Advances and Challenges in Radiation Oncology for Gynaecological Malignancies (Deadline: 29 February 2024)
- Tumor Microenvironment and Non-coding RNAs: Where We Are Now and Where We Are Going To (Deadline: 29 February 2024)
- Targeting Apoptotic Pathways in Cancer Therapy (Deadline: 29 February 2024)
- Targeted Treatments in Cancer 2.0 (Deadline: 29 February 2024)
- Advances in Head and Neck and Skin Cancer (Deadline: 29 February 2024)
- Molecular Mechanisms and Therapies of Malignant Mesothelioma 2.0 (Deadline: 13 March 2024)
- Molecular Advances in Gastric Cancer (Deadline: 15 March 2024)
- Oncolytic Viruses for Cancer Immunotherapy (Deadline: 15 March 2024)
- New Advances on Photosensitiser or Inhibitors Molecules for Cancer Treatment (Deadline: 15 March 2024)
- Genomics and Proteomics of Cancer Cell Survival and Development (Deadline: 25 March 2024)
- Stroma in Inflammation and Cancer in the Gastrointestinal System (Deadline: 30 March 2024)
- Biomarkers in Cancers: New Advances (Deadline: 30 March 2024)
- Molecular Research of DNA Methylation in Cancer Therapy (Deadline: 31 March 2024)
- Osteosarcoma: Current Advances from Molecular and Cellular Mechanisms to Therapy (Deadline: 31 March 2024)
- Molecular Research and Treatment of Breast Cancer 3.0 (Deadline: 31 March 2024)
- New Diagnostic Tools and Biomarkers in Oncological Diseases 2.0 (Deadline: 31 March 2024)
- Liquid Biopsies in Oncology II (Deadline: 31 March 2024)
- Sarcoma 2.0 (Deadline: 31 March 2024)
- NF-κB and Cancer 2.0 (Deadline: 31 March 2024)
- Molecular Aspects of Adrenal Diseases and Carcinoma (Deadline: 31 March 2024)
- Non-coding RNA (ncRNA) in Cancer 2.0 (Deadline: 31 March 2024)
- Intratumor Heterogeneity and Therapy Resistance of Solid Tumors: Treacherous Apoptosis, Reversible Senescence, Genome Chaos, and More (Deadline: 31 March 2024)
- Molecular Research of Natural Products in Cancer Diseases (Deadline: 31 March 2024)
- The Role of MicroRNA in Tumor Development and Treatment (Deadline: 31 March 2024)
- Molecular Research on Oral Cancer (Deadline: 31 March 2024)
- Molecular Biology of Cancer—Implications for Diagnosis and Treatment 2.0 (Deadline: 15 April 2024)
- Molecular Mechanisms and Therapies of Myeloid Leukaemia 2.0 (Deadline: 30 April 2024)
- Epigenetic Genes, Biomarkers and Immunotherapy in Cancers (Deadline: 30 April 2024)
- Thyroid Disease and Thyroid Cancer 2.0 (Deadline: 30 April 2024)
- Cancer Biology: From Genetic Aspects to Treatment (Deadline: 30 April 2024)
- Regulation and Targeting of Ferroptosis in Tumor and Beyond (Deadline: 31 May 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
